Circulation. Arrhythmia and electrophysiology最新文献

{"title":"His-Ventricular Interval and Incident Pacemaker Implant in Over 3000 Ambulatory Patients Undergoing Invasive Electrophysiologic Procedures.","authors":"Daniel Pipilas, Thomas Sommers, Gregory F Michaud, Patrick T Ellinor, Shaan Khurshid","doi":"10.1161/CIRCEP.124.013285","DOIUrl":"10.1161/CIRCEP.124.013285","url":null,"abstract":"","PeriodicalId":10319,"journal":{"name":"Circulation. Arrhythmia and electrophysiology","volume":" ","pages":"e013285"},"PeriodicalIF":9.1,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142726515","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Lesion Morphometry of the Pentaspline Pulsed Field Ablation Catheter: Understanding Catheter Pose, Rotation, and Dosing.","authors":"Keita Watanabe, Moritz Nies, Vivek Y Reddy, Jacob S Koruth","doi":"10.1161/CIRCEP.124.013208","DOIUrl":"10.1161/CIRCEP.124.013208","url":null,"abstract":"<p><strong>Background: </strong>The pentaspline pulsed field ablation catheter achieves pulmonary vein isolation using 8 stacked, pose-specific applications with rotation. The morphology of pose-specific, single or double applications has not been described.</p><p><strong>Methods: </strong>One or 2 applications were delivered to select veins and discrete atrial and ventricular sites in 9 swine. General anesthesia with neuromuscular paralysis ensured a stable position. Preablation, postablation, and serial intraprocedural mappings were performed to characterize electrical vein isolation and dynamic voltage changes. Upon euthanize at 2 days (7 of 9 swine), hearts were subject to pathological examination.</p><p><strong>Results: </strong>Six superior vena cavae received single or double applications in basket pose without rotation. Despite incomplete dosing, acute electrical isolation occurred in 4 of 6 veins. None recovered conduction over 40 minutes, but all 3 isolated veins that were remapped at 2 days had reconnected. Lesions were linear (15-16 mm) with gaps and significantly wider with double versus single applications (8.2±2.8 versus 6.1±2.0 mm; <i>P</i>=0.02). Similar lesions, with acute isolation and subsequent reconnection, were observed in 3 of 4 ablated pulmonary veins. Double flower pose applications to the posterior atrium created wide (≈40×30 mm) confluent lesions, whereas single applications resulted in curvilinear lesions with variable gaps. Flower pose lesions (single or double) in the right ventricle were flower-shaped, linear with gaps, and with depths up to ≈5 mm.</p><p><strong>Conclusions: </strong>The pentaspline catheter in the basket pose creates perivenous linear lesions with gaps. Single applications in flower pose generate narrow linear lesions with variable gaps, whereas double applications result in wide, confluent lesions.</p>","PeriodicalId":10319,"journal":{"name":"Circulation. Arrhythmia and electrophysiology","volume":" ","pages":"e013208"},"PeriodicalIF":9.1,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142750155","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Artificial Intelligence-Based Feature Analysis of Pulmonary Vein Morphology on Computed Tomography Scans and Risk of Atrial Fibrillation Recurrence After Catheter Ablation: A Multi-Site Study.","authors":"Golnoush Asaeikheybari, Majd El-Harasis, Amit Gupta, M Benjamin Shoemaker, John Barnard, Joshua Hunter, Rod S Passman, Han Sun, Hyun Su Kim, Taylor Schilling, William Telfer, Britta Eldridge, Po-Hao Chen, Abhishek Midya, Bibin Varghese, Samuel J Harwood, Alison Jin, Sojin Y Wass, Aleksandar Izda, Kevin Park, Abel Abraham, David R Van Wagoner, Animesh Tandon, Mina K Chung, Anant Madabhushi","doi":"10.1161/CIRCEP.123.012679","DOIUrl":"10.1161/CIRCEP.123.012679","url":null,"abstract":"<p><strong>Background: </strong>Atrial fibrillation (AF) recurrence is common after catheter ablation. Pulmonary vein (PV) isolation is the cornerstone of AF ablation, but PV remodeling has been associated with the risk of AF recurrence. We aimed to evaluate whether artificial intelligence-based morphological features of primary and secondary PV branches on computed tomography images are associated with AF recurrence post-ablation.</p><p><strong>Methods: </strong>Two artificial intelligence models were trained for the segmentation of computed tomography images, enabling the isolation of PV branches. Patients from Cleveland Clinic (N=135) and Vanderbilt University (N=594) were combined and divided into 2 sets for training and cross-validation (D₁, n=218) and internal testing (D₂, n=511). An independent validation set (D₃, N=80) was obtained from University Hospitals of Cleveland. We extracted 48 fractal-based and 12 shape-based radiomic features from primary and secondary PV branches of patients with AF recurrence (AF+) and without recurrence after catheter ablation of AF (AF-). To predict AFrecurrence, 3 Gradient Boosting classification models based on significant features from primary (M_<i>p</i>), secondary (M_<i>s</i>), and combined (M_<i>c</i>) PV branches were built.</p><p><strong>Results: </strong>Features relating to primary PVs were found to be associated with AF recurrence. The M_<i>p</i> classifier achieved area under the curve values of 0.73, 0.71, and 0.70 across the 3 datasets. AF+ cases exhibited greater surface complexity in their primary PV area, as evidenced by higher fractal dimension values compared with AF- cases. The M_<i>s</i> classifier results revealed a weaker association with AF+, suggesting higher relevance to AF recurrence post-ablation from primary PV branch morphology.</p><p><strong>Conclusions: </strong>This largest multi-institutional study to date revealed associations between artificial intelligence-extracted morphological features of the primary PV branches with AF recurrence in 809 patients from 3 sites. Future work will focus on enhancing the predictive ability of the classifier by integrating clinical, structural, and morphological features, including left atrial appendage and left atrium-related characteristics.</p>","PeriodicalId":10319,"journal":{"name":"Circulation. Arrhythmia and electrophysiology","volume":" ","pages":"e012679"},"PeriodicalIF":9.1,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11662226/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142766738","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Comparison of Procedural Outcomes of Lumenless Fixed-Helix Versus Stylet-Driven Extendable-Helix Lead Systems in Left Bundle Branch Pacing: COMPARE LBBP.","authors":"Jenish P Shroff, Anugrah Nair, Deep Chandh Raja, Sreevilasam P Abhilash, Simon Fiorese, Jonathan P Ariyaratnam, Walter P Abhayaratna, Prashanthan Sanders, Pugazhendhi Vijayaraman, Rajeev K Pathak","doi":"10.1161/CIRCEP.124.013385","DOIUrl":"10.1161/CIRCEP.124.013385","url":null,"abstract":"<p><strong>Background: </strong>Left bundle branch pacing (LBBP) has emerged as a safe and effective alternative to right ventricular pacing. Traditionally, LBBP is performed with lumenless lead (LLL); however, the use of stylet-driven lead (SDL) is on rise. We aimed to assess acute success and procedural outcomes of SDL versus LLL for LBBP.</p><p><strong>Methods: </strong>One hundred consecutive patients with bradyarrhythmia, indication of cardiac resynchronization therapy, or ablate and pace strategy were randomized in a 1:1 fashion to the SDL and LLL arms. Tendril STS lead with a CPS Locator 3D catheter and SelectSecure 3830 lead with a C315HIS catheter were used in the SDL and LLL arms, respectively. LBBP was confirmed by standard criteria with measurements done on Labsystem Pro.</p><p><strong>Results: </strong>Patients in the LLL arm were significantly younger (71.9±11 versus 76.4±8.9 years; <i>P</i>=0.02); all other baseline characteristics were not significantly different. Acute success in LBBP was similar with SDL versus LLL (90% versus 92%; <i>P</i>=0.7). In patients with successful LBBP, screw attempts were not significantly different between the groups (2.3±1.7 in SDL versus 1.9±1.3 in LLL; <i>P</i>=0.2). Implant duration (11±9.6 versus 9.9±7.1 minutes; <i>P</i>=0.4), mean fluoroscopy dose (65.3±82.7 versus 53.5±50.5 mGy; <i>P</i>=0.5), and fluoroscopy time (7.8±4.8 versus 7.4±4 minutes; <i>P</i>=0.7) were also not different in the SDL versus the LLL arm, respectively. Incidence of lead failure (<i>P</i>=0.6), microdislodgement (<i>P</i>=1), and macrodislodgement (<i>P</i>=0.6) were not significantly different. Pacing threshold was comparable at implant and on follow-up at 1, 3, and 6 months.</p><p><strong>Conclusions: </strong>LBBP was feasible with both lead systems with similar success rate and low capture threshold. No significant difference was observed in procedure duration or fluoroscopy use. No major complications were recorded with either lead.</p><p><strong>Registration: </strong>URL: https://www.anzctr.org.au; Unique identifier: ACTRN12624000304538.</p>","PeriodicalId":10319,"journal":{"name":"Circulation. Arrhythmia and electrophysiology","volume":" ","pages":"e013385"},"PeriodicalIF":9.1,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142750131","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Pulsed Field Ablation as First-Line Therapy for Atrial Fibrillation: A Substudy of the EU-PORIA Registry.","authors":"Anna Füting, Kars Neven, Stefano Bordignon, Tobias Reichlin, Yuri Blaauw, Jim Hansen, Raquel Adelino, Alexandre Ouss, Laurent Roten, Bart A Mulder, Martin H Ruwald, Roberto Mené, Pepijn van der Voort, Nico Reinsch, Thomas Kueffer, Serge Boveda, Elizabeth M Albrecht, Jonathan D Raybuck, Brad Sutton, Kyoung Ryul Julian Chun, Boris Schmidt","doi":"10.1161/CIRCEP.124.013088","DOIUrl":"10.1161/CIRCEP.124.013088","url":null,"abstract":"<p><strong>Background: </strong>Recent studies have demonstrated the benefit of early ablation in preventing the progression of atrial fibrillation (AF). Clinical practice has reflected this shift in AF management and no longer requires patients to fail antiarrhythmic drugs (AADs) before receiving ablation. However, there is limited evidence on outcomes with pulsed field ablation (PFA) as a first-line therapy. Examination of real-world data may shed light on clinical practices and the effectiveness of PFA with and without a prior history of AAD usage.</p><p><strong>Methods: </strong>European Real World Outcomes with Pulsed Field Ablation is an all-comer AF registry enrolling consecutive patients treated with the pentaspline PFA catheter at 7 high-volume centers in Europe. This subanalysis evaluates patients with a history of class I/III AAD use versus those with no documented history of class I/III AAD use (first-line patients). Patients with incomplete AAD history, long-standing persistent AF, and those undergoing a repeat ablation procedure were excluded. Patients were treated and followed based on institutional standard of care. Any episode of atrial tachycardia or AF lasting longer than 30 s was considered an arrhythmia recurrence.</p><p><strong>Results: </strong>Of 1233 patients enrolled in European real world outcomes with pulsed field ablation, 1091 met the inclusion criteria (mean age, 66 years; 40% females; and persistent AF, 36%). Pulmonary vein isolation-only was used in 90% of the patients, and 10% received extra-PV ablation. Ablation as the first-line approach was chosen in 589 patients, and 502 patients had prior class I/III AAD use. In the first-line PFA group, paroxysmal AF was more frequent (68% versus 59%; <i>P</i><0.001), and pulmonary vein isolation-only was more frequent (93% versus 86%; <i>P</i><0.001). At 1-year follow-up, freedom from AF/atrial tachycardia recurrence was similar in the ablation-first versus the ablation after failed AAD group (78% versus 74%, respectively; <i>P</i>=0.076).</p><p><strong>Conclusion: </strong>In this large real-world PFA registry, freedom from AF/atrial tachycardia recurrence after 1 year was similar in patients undergoing PFA as a first-line treatment and those with prior failed AAD therapy.</p><p><strong>Registration: </strong>URL: https://www.clinicaltrials.gov; Unique identifier: NCT05823818.</p>","PeriodicalId":10319,"journal":{"name":"Circulation. Arrhythmia and electrophysiology","volume":" ","pages":"e013088"},"PeriodicalIF":9.1,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142726518","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Electrophysiological Phenotype-Genotype Study of Sustained Monomorphic Ventricular Tachycardia in Inherited, High Arrhythmic Risk, Left Ventricular Cardiomyopathy.","authors":"Eva Cabrera-Borrego, Francisco J Bermúdez-Jiménez, Alessio Gasperetti, Harikrishna Tandri, Pablo J Sánchez-Millán, Manuel Molina-Lerma, Ivo Roca-Luque, Sara Vázquez-Calvo, Paolo Compagnucci, Michela Casella, Claudio Tondo, Petr Peichl, Giovani Peretto, Elena Paiotti, Ardan M Saguner, Víctor Castro-Urda, Nerea Mora-Ayestarán, José M Larrañaga-Moreira, Pablo Fernández de-Aspe, Roberto Barriales-Villa, Carmen Muñoz-Esparza, Esther Zorio, Julia Martínez-Solé, Luis R Lopes, Johanna B Tonko, Pier D Lambiase, Perry M Elliott, Moisés Rodríguez-Mañero, Victoria Cañadas-Godoy, Sebastian Giacoman, Miguel Álvarez-López, Rosa Macías-Ruiz, William J McKenna, Luis Tercedor-Sánchez, Juan Jiménez-Jáimez","doi":"10.1161/CIRCEP.124.013145","DOIUrl":"10.1161/CIRCEP.124.013145","url":null,"abstract":"<p><strong>Background: </strong>Among inherited cardiomyopathies involving the left ventricle, whether dilated or not, certain genotypes carry a well-established arrhythmic risk, notably manifested as sustained monomorphic ventricular tachycardia (SMVT). Nonetheless, the precise localization and electrophysiological profile of this substrate remain undisclosed across different genotypes.</p><p><strong>Methods: </strong>Patients diagnosed with cardiomyopathy and left ventricle involvement due to high-risk genetic variants and SMVT treated by electrophysiological study were recruited from 18 European/US centers. Electrophysiological study, imaging, and outcomes data after ablation were assessed in relation to genotype.</p><p><strong>Results: </strong>Seventy-one patients were included (49.6 Q1-Q3 [40-60] years, 76% men). They were divided into 4 groups according to the affected protein: desmosomal (<i>DSP</i>, <i>PKP2</i>, <i>DSG2</i>, and <i>DSC2</i>), nuclear membrane (<i>LMNA</i> and <i>TMEM43</i>), cytoskeleton (<i>FLNC</i> and <i>DES</i>), and sarcoplasmic reticulum (<i>PLN</i>). Desmosomal genes, <i>TMEM43</i>, and <i>PLN</i> were associated with biventricular disease, while variants in <i>LMNA</i> and cytoskeleton genes had predominant left ventricle involvement (<i>P</i>=0.001). The location of the clinical-SMVT substrate was significantly different based on genotype (<i>P</i>=0.005). <i>DSP</i> and cytoskeleton genes presented SMVTs with right bundle branch block morphology, which origin was identified in the inferolateral segments of the left ventricle. The other desmosomal genes (<i>PKP2</i> and <i>DSG2</i>), along with <i>TMEM43</i>, showed SMVTs with left bundle branch block morphology and predominantly right ventricular substrate. In contrast, <i>LMNA</i> substrate was mainly observed in the interventricular septum. During a median of 26 Q1-Q3 (10.6-65) months, 27% of patients experienced recurrences of clinical SMVT with differences between genotypes (log-rank 0.016). Nuclear membrane genes demonstrated the highest recurrence rate compared with desmosomal genes (hazard ratio, 4.56 [95% CI, 1.5-13.8]).</p><p><strong>Conclusions: </strong>The anatomic substrate of SMVTs shows a strong correlation with the underlying genotype, electrocardiographic morphology, and recurrence rate. Particularly, patients with nuclear membrane gene variants have a significantly higher recurrence rate compared with those with desmosomal gene variants.</p>","PeriodicalId":10319,"journal":{"name":"Circulation. Arrhythmia and electrophysiology","volume":" ","pages":"e013145"},"PeriodicalIF":9.1,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142750150","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Inappropriate Therapy and Shock Rates Between the Subcutaneous and Transvenous Implantable Cardiac Defibrillator: A Secondary Analysis of the PRAETORIAN Trial.","authors":"Louise R A Olde Nordkamp, Shari Pepplinkhuizen, Abdul Ghani, Lucas V A Boersma, Juergen Kuschyk, Mikhael F El-Chami, Elijah R Behr, Tom F Brouwer, Stefan Kääb, Suneet Mittal, Anne-Floor B E Quast, Willeke van der Stuijt, Lonneke Smeding, Jolien A de Veld, Jan G P Tijssen, Nick R Bijsterveld, Sergio Richter, Marc A Brouwer, Joris R de Groot, Kirsten M Kooiman, Pier D Lambiase, Petr Neuzil, Kevin Vernooy, Marco Alings, Timothy R Betts, Frank A L E Bracke, Martin C Burke, Jonas S S G de Jong, David J Wright, Ward P J Jansen, Zachary I Whinnett, Peter Nordbeck, Michael Knaut, Berit T Philbert, Jurren M van Opstal, Alexandru B Chicos, Cornelis P Allaart, Alida E Borger van der Burg, Jose M Dizon, Marc A Miller, Dmitry Nemirovsky, Ralf Surber, Gaurav A Upadhyay, Raul Weiss, Anouk de Weger, Arthur A M Wilde, Reinoud E Knops","doi":"10.1161/CIRCEP.124.012836","DOIUrl":"10.1161/CIRCEP.124.012836","url":null,"abstract":"<p><strong>Background: </strong>Inappropriate therapy (IAT) is an undesirable side effect of implantable cardiac defibrillator (ICD) therapy. Early studies with the subcutaneous ICD (S-ICD) showed relatively high inappropriate shock (IAS) rates. The PRAETORIAN (Prospective Randomized Comparison of Subcutaneous and Transvenous Implantable Cardioverter Defibrillator Therapy) trial demonstrated that the S-ICD is noninferior to the transvenous ICD (TV-ICD) with regard to the combined end point of IAS and complications. This secondary analyses evaluates all IAT in the PRAETORIAN trial.</p><p><strong>Methods: </strong>This international, multicenter trial randomized 849 patients with an indication for ICD therapy between S-ICD (n=426) and TV-ICD therapy (n=423). ICD programming was mandated by protocol. All analysis were performed in the modified intention-to-treat population.</p><p><strong>Results: </strong>In both groups 42 patients experienced IAT (48-month Kaplan-Meier estimated cumulative incidence, 9.9% and 10.1%, respectively; hazard ratio (HR), 0.99 [95% CI, 0.65-1.52]; <i>P</i>=0.97). There was no significant difference in patients experiencing IAS between both groups (<i>P</i>=0.14). In the S-ICD group, 81 IAT episodes with 124 IAS and 1 inappropriate antitachycardia pacing occurred versus 89 IAT episodes with 130 IAS and 124 inappropriate antitachycardia pacing in the TV-ICD group. IAT episodes were most frequently caused by supraventricular tachycardias in the TV-ICD group (n=83/89) versus cardiac oversensing in the S-ICD group (n=40/81). In the TV-ICD group, a baseline heart rate >80 bpm (HR, 1.99 [95% CI, 1.05-3.76]; <i>P</i>=0.03), a history of atrial fibrillation (HR, 2.66 [95% CI, 1.41-5.02]; <i>P</i>=0.003), and smoking (HR, 2.46 [95% CI, 1.31-4.09]; <i>P</i>=0.005) were independent predictors for IAT. A QRS duration >120 ms was an independent predictor for IAT caused by cardiac oversensing in the S-ICD group (HR, 3.13 [95% CI, 1.34-7.31]; <i>P</i>=0.008). Post-IAS interventions significantly reduced IAS recurrence in both groups (<i>P</i>=0.046).</p><p><strong>Conclusions: </strong>There was no significant difference in IAT and IAS rates between the S-ICD and TV-ICD in a conventional ICD population, but causes and predictors for IAT differed between the devices. After the first IAS, an intervention significantly reduced the recurrence rate of IAS.</p><p><strong>Registration: </strong>URL: https://www.clinicaltrials.gov; Unique identifier: NCT01296022.</p>","PeriodicalId":10319,"journal":{"name":"Circulation. Arrhythmia and electrophysiology","volume":" ","pages":"e012836"},"PeriodicalIF":9.1,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142766784","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Antithrombotic Strategies When Using Epicardial Carbon Dioxide Insufflation During Percutaneous Epicardial Access.","authors":"Corentin Chaumont, Adrian M Petzl, Alireza Oraii, Kristine Conn, Frederic Anselme, Francis E Marchlinski, Matthew C Hyman","doi":"10.1161/CIRCEP.124.013310","DOIUrl":"10.1161/CIRCEP.124.013310","url":null,"abstract":"","PeriodicalId":10319,"journal":{"name":"Circulation. Arrhythmia and electrophysiology","volume":" ","pages":"e013310"},"PeriodicalIF":9.1,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142726507","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Exercise Training Improves Cognitive Function and Neurovascular Control: A Secondary Analysis of the Exercise Training in Heart Failure With Reduced Ejection Fraction and Permanent Atrial Fibrillation: A Randomized Clinical Trial.","authors":"Guilherme Veiga Guimarães, Paulo Roberto Chizzola, Veridiana Moraes D'Avila, Paulo Roberto Santo Silva, Leandro Silva Alves, Edimar Alcides Bocchi","doi":"10.1161/CIRCEP.124.013193","DOIUrl":"10.1161/CIRCEP.124.013193","url":null,"abstract":"","PeriodicalId":10319,"journal":{"name":"Circulation. Arrhythmia and electrophysiology","volume":" ","pages":"e013193"},"PeriodicalIF":9.1,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142459450","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Performance of Atrial Fibrillation Burden Trends for Stroke Risk Stratification.","authors":"Jonathan P Piccini, Evan J Stanelle, Cody C Johnson, Elaine M Hylek, Rahul Kanwar, Dhanunjaya R Lakkireddy, Suneet Mittal, James Peacock, Andrea M Russo, Dana Soderlund, Mellanie True Hills, Rod S Passman","doi":"10.1161/CIRCEP.123.012394","DOIUrl":"10.1161/CIRCEP.123.012394","url":null,"abstract":"<p><strong>Background: </strong>Atrial fibrillation (AF) is associated with an increased risk of stroke, yet the limitations of conventional monitoring have restricted our understanding of AF burden risk thresholds. Predictive algorithms incorporating continuous AF burden measures may be useful for predicting stroke. This study evaluated the performance of temporal AF burden trends as predictors of stroke from a large cohort with insertable cardiac monitors.</p><p><strong>Methods: </strong>Using deidentified data from Optum Clinformatics Data Mart (2007-2019) linked with the Medtronic CareLink insertable cardiac monitor database, we identified patients with an insertable cardiac monitor for AF management (n=1197), suspected AF (n=1611), and cryptogenic stroke (n=2205). Daily AF burden was transformed into simple moving averages, and temporal AF burden trends were defined as the comparison of unique simple moving average pairs. Classification trees were used to predict ischemic stroke, and AF burden significance was quantified using bootstrapped mean variable importance.</p><p><strong>Results: </strong>Of 5013 patients (age, 69.2±11.7 years; 50% male; CHA₂DS₂-VASc, 3.7±1.9) who met inclusion criteria, 869 had an ischemic stroke over 2 409 437 days total follow-up. Prior stroke or transient ischemic attack (variable importance, 13.13) was the number 1 predictor of future stroke followed by no prior diagnosis of AF (7.35) and AF burden trends in follow-up (2.59). Temporal proximity of AF and risk of stroke differed by device indication (simple moving averages: AF management, <8 days and suspected AF and cryptogenic stroke, 8-21 days). Together, baseline characteristics and AF burden trends performed optimally for the area under the receiver operating characteristic curve (0.73), specificity (0.70), and relative risk (5.00).</p><p><strong>Conclusions: </strong>AF burden trends may provide incremental prognostic value as leading indicators of stroke risk compared with conventional schemes.</p>","PeriodicalId":10319,"journal":{"name":"Circulation. Arrhythmia and electrophysiology","volume":" ","pages":"e012394"},"PeriodicalIF":9.1,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11575904/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142496198","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}